{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:26:31Z","timestamp":1787318791482,"version":"build-2736575974"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Many providers require cessation of gender-affirming hormone therapy (GAHT) for transgender patients prior to undergoing masculinizing chest surgery (MCS) due to concerns about increased adverse events in the presence of exogenous hormones. Evidence has suggested that continuation of GAHT for certain patients may be safe for gender-affirming procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of this study was to compare adverse event rates for GAHT cessation vs GAHT continuation in patients undergoing MCS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter, retrospective study included patients at the Cleveland Clinic and MetroHealth System who underwent MCS between 2016 and 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 236 patients who met the inclusion criteria. Of these, 172 (72.9%) discontinued testosterone GAHT prior to surgery and 64 (27.1%) continued the therapy. Mean [standard deviation] age at surgery was 25 [8] years, and mean BMI was 29.5 [6.6] kg\/m.2 The median duration of testosterone therapy was 18 months (range, 0-300 months). There was no significant difference in tobacco use (P = 0.73), diabetes (P = 0.54), thrombophilia (P = 0.97), or history of thromboembolism (P = 0.39). Most patients underwent the double-incision free nipple graft technique (77.9%). There was no significant difference in surgical time (P = 0.12), intraoperative complications (P = 0.54), or postoperative complications (P = 0.34). The most common complication was postoperative bleeding\/hematoma (7.2%). Other complications included seroma (2.1%), infection (1.3%), and nipple graft failure (0.4%). There were no thromboembolic complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There is no significant difference in the incidence of perioperative adverse events for patients who continue GAHT preoperatively vs patients who stop GAHT prior to MCS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence: 4<\/jats:title>\n                    <jats:p\/>\n                  <\/jats:sec>","DOI":"10.1093\/asj\/sjac091","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T13:36:51Z","timestamp":1649857011000},"page":"1009-1016","source":"Crossref","is-referenced-by-count":23,"title":["The Effect of Preoperative Gender-Affirming Hormone Therapy Use on Perioperative Adverse Events in Transmasculine Individuals Undergoing Masculinizing Chest Surgery for Gender Affirmation"],"prefix":"10.1093","volume":"42","author":[{"given":"Shannon S","family":"Wu","sequence":"first","affiliation":[{"name":"Cleveland Clinic Lerner College of Medicine of Case Western Reserve University , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A","family":"Raymer","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Cleveland Clinic , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram R","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, MetroHealth System , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Isakov","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Cleveland Clinic , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile A","family":"Ferrando","sequence":"additional","affiliation":[{"name":"Transgender Surgical Services, Cleveland Clinic , Cleveland, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"issue":"4","key":"2022082414080693200_CIT0001","doi-asserted-by":"crossref","first-page":"873e","DOI":"10.1097\/PRS.0000000000003225","article-title":"Top surgery in transgender men: how far can you push the envelope?","volume":"139","author":"Bluebond-Langner","year":"2017","journal-title":"Plast Reconstr Surg."},{"issue":"1","key":"2022082414080693200_CIT0002","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s13178-017-0295-8","article-title":"Barriers to gender-affirming care for transgender and gender nonconforming individuals","volume":"15","author":"Puckett","year":"2018","journal-title":"Sex Res Social Policy."},{"issue":"6","key":"2022082414080693200_CIT0003","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bjps.2011.11.053","article-title":"Female-to-male transgender chest reconstruction: a large consecutive, single-surgeon experience","volume":"65","author":"Berry","year":"2012","journal-title":"J Plast Reconstr Aesthet Surg."},{"issue":"2","key":"2022082414080693200_CIT0004","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jamasurg.2018.4598","article-title":"Association of surgical risk with exogenous hormone use in transgender patients: a systematic review","volume":"154","author":"Boskey","year":"2019","journal-title":"JAMA Surg"},{"issue":"1","key":"2022082414080693200_CIT0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/asj\/sjx116","article-title":"Female-to-male gender affirming top surgery: a single surgeon\u2019s 15-year retrospective review and treatment algorithm","volume":"38","author":"McEvenue","year":"2017","journal-title":"Aesthet Surg J."},{"issue":"2","key":"2022082414080693200_CIT0006","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1213\/ANE.0000000000003371","article-title":"The perioperative care of the transgender patient","volume":"127","author":"Tollinche","year":"2018","journal-title":"Anesth Analg."},{"key":"2022082414080693200_CIT0007","first-page":"9","article-title":"Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study","volume":"33","author":"Sweetland","year":"2009","journal-title":"BMJ."},{"issue":"4","key":"2022082414080693200_CIT0008","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jvsv.2020.11.017","article-title":"Timing and characteristics of venous thromboembolism after noncancer surgery","volume":"9","author":"Exp\u00f3sito-Ruiz","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord."},{"issue":"2-3","key":"2022082414080693200_CIT0009","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.disamonth.2005.02.003","article-title":"Thrombosis risk assessment as a guide to quality patient care","volume":"51","author":"Caprini","year":"2005","journal-title":"Dis Mon."},{"issue":"Supplement_2","key":"2022082414080693200_CIT0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/asj\/sjab178","volume":"41","author":"The Aesthetic Society\u2019s Cosmetic Surgery National Data Bank","year":"2021","journal-title":"Aesthet Surg J."},{"issue":"7","key":"2022082414080693200_CIT0011","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jamasurg.2017.6231","article-title":"Temporal trends in gender-affirming surgery among transgender patients in the United States","volume":"153","author":"Canner","year":"2018","journal-title":"JAMA Surg."},{"issue":"5","key":"2022082414080693200_CIT0012","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/SAP.0000000000001896","article-title":"Female-to-male transgender chest contouring: a systematic review of outcomes and knowledge gaps","volume":"83","author":"Cohen","year":"2019","journal-title":"Ann Plast Surg."},{"issue":"6","key":"2022082414080693200_CIT0013","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00266-017-0935-7","article-title":"Creation of an aesthetic male nipple areolar complex in female-to-male transgender chest reconstruction","volume":"41","author":"Agarwal","year":"2017","journal-title":"Aesthetic Plast Surg."},{"issue":"4","key":"2022082414080693200_CIT0014","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/PRS.0000000000007786","article-title":"Perioperative transgender hormone management: avoiding venous thromboembolism and other complications","volume":"147","author":"Hontscharuk","year":"2021","journal-title":"Plast Reconstr Surg."},{"issue":"2","key":"2022082414080693200_CIT0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamainternmed.2019.5135","article-title":"Association of testosterone therapy with risk of venous thromboembolism among men with and without hypogonadism","volume":"180","author":"Walker","year":"2020","journal-title":"JAMA Intern Med."},{"key":"2022082414080693200_CIT0016","doi-asserted-by":"crossref","first-page":"i5968","DOI":"10.1136\/bmj.i5968","article-title":"Testosterone treatment and risk of venous thromboembolism: population based case-control study","volume":"355","author":"Martinez","year":"2016","journal-title":"BMJ."},{"issue":"1","key":"2022082414080693200_CIT0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03632.x","article-title":"Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses","volume":"72","author":"Elamin","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2022082414080693200_CIT0018","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jsxm.2021.04.006","article-title":"Risk for venous thromboembolism in transgender patients undergoing cross-sex hormone treatment: a systematic review","volume":"18","author":"Kotamarti","year":"2021","journal-title":"J Sex Med."},{"issue":"2","key":"2022082414080693200_CIT0019","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ecl.2019.02.002","article-title":"Gender confirmation surgery for the endocrinologist","volume":"48","author":"Narayan","year":"2019","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"4","key":"2022082414080693200_CIT0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/0092623X.2012.736920","article-title":"A prospective study on sexual function and mood in female-to-male transsexuals during testosterone administration and after sex reassignment surgery","volume":"39","author":"Costantino","year":"2013","journal-title":"J Sex Marital Ther"},{"key":"2022082414080693200_CIT0021","volume-title":"Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People","author":"Deutsch","year":"2016"},{"issue":"2","key":"2022082414080693200_CIT0022","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1743-6109.2011.02564.x","article-title":"Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study","volume":"9","author":"Gorin-Lazard","year":"2012","journal-title":"J Sex Med."},{"issue":"1","key":"2022082414080693200_CIT0023","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/trgh.2015.0008","article-title":"A systematic review of the effects of hormone therapy on psychological functioning and quality of life in transgender individuals","volume":"1","author":"White Hughto","year":"2016","journal-title":"Transgend Health."},{"issue":"4","key":"2022082414080693200_CIT0024","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(16)00036-X","article-title":"Testosterone therapy for transgender men","volume":"5","author":"Irwig","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"12","key":"2022082414080693200_CIT0025","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/jsm.12698","article-title":"Effects of three different testosterone formulations in female-to-male transsexual persons","volume":"11","author":"Pelusi","year":"2014","journal-title":"J Sex Med."},{"issue":"3","key":"2022082414080693200_CIT0026","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bjps.2017.09.003","article-title":"Subcutaneous mastectomy in female-to-male transsexuals: optimizing perioperative and operative management in 8 years clinical experience","volume":"71","author":"Wolter","year":"2018","journal-title":"J Plast Reconstr Aesthet Surg."},{"key":"2022082414080693200_CIT0027","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/1457496916645964","article-title":"Chest-wall contouring surgery in female-to-male transgender patients: a one-center retrospective analysis of applied surgical techniques and results","volume":"106","author":"K\u00e4\u00e4ri\u00e4inen","year":"2017","journal-title":"Scand J Surg."},{"issue":"6","key":"2022082414080693200_CIT0028","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/SAP.0000000000001354","article-title":"Masculinizing top surgery: a systematic review of techniques and outcomes","volume":"80","author":"Wilson","year":"2018","journal-title":"Ann Plast Surg."},{"issue":"1","key":"2022082414080693200_CIT0029","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/SAP.0b013e318243355f","article-title":"Hematoma after mastectomy with immediate reconstruction: an analysis of risk factors in 883 patients","volume":"71","author":"Seth","year":"2013","journal-title":"Ann Plast Surg."},{"issue":"7","key":"2022082414080693200_CIT0030","doi-asserted-by":"crossref","first-page":"NP763","DOI":"10.1093\/asj\/sjab028","article-title":"Systematic review and meta-analysis of complications following mastectomy and prosthetic reconstruction in patients with and without prior breast augmentation","volume":"41","author":"Chicco","year":"2021","journal-title":"Aesthet Surg J."},{"issue":"10","key":"2022082414080693200_CIT0031","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/asj\/sjx062","article-title":"Incidence and risk factors for major hematomas in aesthetic surgery: analysis of 129,007 patients","volume":"37","author":"Kaoutzanis","year":"2017","journal-title":"Aesthet Surg J."},{"issue":"6","key":"2022082414080693200_CIT0032","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1054\/bjps.2001.3623","article-title":"The prevention of haematoma following rhytidectomy: a review of 1078 consecutive facelifts","volume":"54","author":"Grover","year":"2001","journal-title":"Br J Plast Surg."},{"issue":"7","key":"2022082414080693200_CIT0033","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/01.prs.0000191182.70617.e9","article-title":"Reducing the incidence of hematoma requiring surgical evacuation following male rhytidectomy: a 30-year review of 985 cases","volume":"116","author":"Baker","year":"2005","journal-title":"Plast Reconstr Surg."},{"issue":"10","key":"2022082414080693200_CIT0034","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bjps.2008.03.043","article-title":"Complications in abdominoplasty: a risk factor analysis","volume":"62","author":"Momeni","year":"2009","journal-title":"J Plast Reconstr Aesthet Surg."},{"issue":"2","key":"2022082414080693200_CIT0035","doi-asserted-by":"crossref","first-page":"325e","DOI":"10.1097\/PRS.0b013e3182589adb","article-title":"Body contouring in the male weight loss population: assessing gender as a factor in outcomes","volume":"130","author":"Chong","year":"2012","journal-title":"Plast Reconstr Surg."},{"issue":"2","key":"2022082414080693200_CIT0036","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/mvre.1993.1019","article-title":"Gender differences in facial skin blood perfusion during basal and heated conditions determined by laser Doppler flowmetry","volume":"45","author":"Mayrovitz","year":"1993","journal-title":"Microvasc Res."},{"issue":"3","key":"2022082414080693200_CIT0037","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"Pt 1","key":"2022082414080693200_CIT0038","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0004563215587763","article-title":"A review of the physical and metabolic effects of cross-sex hormonal therapy in the treatment of gender dysphoria","volume":"53","author":"Seal","year":"2016","journal-title":"Ann Clin Biochem."},{"issue":"10","key":"2022082414080693200_CIT0039","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1245\/s10434-012-2524-y","article-title":"Balancing venous thromboembolism and hematoma after breast surgery","volume":"19","author":"Lovely","year":"2012","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"2022082414080693200_CIT0040","doi-asserted-by":"crossref","first-page":"e1738","DOI":"10.1097\/GOX.0000000000001738","article-title":"Trends in gender-affirming surgery in insured patients in the United States","volume":"6","author":"Lane","year":"2018","journal-title":"Plast Reconstr Surg Glob Open."},{"issue":"4","key":"2022082414080693200_CIT0041","doi-asserted-by":"crossref","first-page":"e1586","DOI":"10.1210\/clinem\/dgaa966","article-title":"No venous thromboembolism increase among transgender female patients remaining on estrogen for gender-affirming surgery","volume":"106","author":"Kozato","year":"2021","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Aesthetic Surgery Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/asj\/advance-article-pdf\/doi\/10.1093\/asj\/sjac091\/43836053\/sjac091.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asj\/article-pdf\/42\/9\/1009\/45509469\/sjac091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asj\/article-pdf\/42\/9\/1009\/45509469\/sjac091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T11:35:40Z","timestamp":1661340940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asj\/article\/42\/9\/1009\/6568173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,4,13]]},"published-print":{"date-parts":[[2022,8,24]]}},"URL":"https:\/\/doi.org\/10.1093\/asj\/sjac091","relation":{},"ISSN":["1090-820X","1527-330X"],"issn-type":[{"value":"1090-820X","type":"print"},{"value":"1527-330X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,4,13]]}}}